{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:27:14Z","timestamp":1790011634895,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["9021087205"],"award-info":[{"award-number":["9021087205"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s11010-021-04349-1","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T16:22:33Z","timestamp":1641399753000},"page":"995-1007","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Linagliptin ameliorates pulmonary fibrosis in systemic sclerosis mouse model via inhibition of endothelial-to-mesenchymal transition"],"prefix":"10.1007","volume":"477","author":[{"given":"Biwei","family":"Pei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9886-6563","authenticated-orcid":false,"given":"Gengyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,5]]},"reference":[{"key":"4349_CR1","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D (2017) Systemic sclerosis. Lancet 390:1685\u20131699","journal-title":"Lancet"},{"key":"4349_CR2","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","volume":"76","author":"M Elhai","year":"2017","unstructured":"Elhai M, Meune C, Boubaya M et al (2017) Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis 76:1897\u20131905","journal-title":"Ann Rheum Dis"},{"key":"4349_CR3","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s13075-015-0872-2","volume":"17","author":"D Khanna","year":"2015","unstructured":"Khanna D, Nagaraja V, Tseng C et al (2015) Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials. Arthritis Res Ther 17:372","journal-title":"Arthritis Res Ther"},{"key":"4349_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/BOR.0b013e32835b1352","volume":"25","author":"B Hu","year":"2013","unstructured":"Hu B, Phan SH (2013) Myofibroblasts. Curr Opin Rheumatol 25:71\u201377","journal-title":"Curr Opin Rheumatol"},{"key":"4349_CR5","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/nm1613","volume":"13","author":"EM Zeisberg","year":"2007","unstructured":"Zeisberg EM, Tarnavski O, Zeisberg M et al (2007) Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13:952\u2013961","journal-title":"Nat Med"},{"key":"4349_CR6","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1152\/physrev.00021.2018","volume":"99","author":"S Piera-Velazquez","year":"2019","unstructured":"Piera-Velazquez S, Jimenez SA (2019) Endothelial to mesenchymal transition: role in physiology and in the pathogenesis of human diseases. Physiol Rev 99:1281\u20131324","journal-title":"Physiol Rev"},{"key":"4349_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/art.39421","volume":"68","author":"FA Mendoza","year":"2016","unstructured":"Mendoza FA, Piera-Velazquez S, Farber JL et al (2016) Endothelial cells expressing endothelial and mesenchymal cell gene products in systemic sclerosis-associated interstitial lung disease lung tissues. Arthritis Rheumatol 68:210\u2013217","journal-title":"Arthritis Rheumatol"},{"key":"4349_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cei.12781","volume":"185","author":"C Klemann","year":"2016","unstructured":"Klemann C, Wagner L, Stephan S, H\u00f6rsten SV (2016) Cut to the chase: a review of CD26\/dipeptidyl peptidase-4\u2032s (DPP4) entanglement in the immune system. Clin Exp Immunol 185:1\u201321","journal-title":"Clin Exp Immunol"},{"key":"4349_CR9","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41574-020-0399-8","volume":"16","author":"CF Deacon","year":"2020","unstructured":"Deacon CF (2020) Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus. Nat Rev Endocrinol 16:642\u2013653","journal-title":"Nat Rev Endocrinol"},{"key":"4349_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/art.41058","volume":"72","author":"A Soare","year":"2020","unstructured":"Soare A, Gy\u00f6rfi HA, Matei AE et al (2020) Dipeptidyl-peptidase-4 as a marker of activated fibroblasts and a potential target for the treatment of fibrosis in systemic sclerosis. Arthritis Rheumatol 72:137\u2013149","journal-title":"Arthritis Rheumatol"},{"key":"4349_CR11","first-page":"104","volume":"356","author":"Y Xin","year":"2017","unstructured":"Xin Y, Wang X, Zhu M et al (2017) Expansion of CD26 positive fibroblast population promotes keloid progression. Exp Cell Res 356:104\u2013113","journal-title":"Exp Cell Res"},{"key":"4349_CR12","doi-asserted-by":"publisher","first-page":"106774","DOI":"10.1016\/j.intimp.2020.106774","volume":"87","author":"Y Liu","year":"2020","unstructured":"Liu Y, Qi YC (2020) Vildagliptin, a CD26\/DPP4 inhibitor, ameliorates bleomycin-induced pulmonary fibrosis via regulating the extracellular matrix. Int Immunopharmacol 87:106774","journal-title":"Int Immunopharmacol"},{"key":"4349_CR13","first-page":"1025","volume":"9","author":"Q Qi","year":"2017","unstructured":"Qi Q, Mao Y, Tian Y et al (2017) Geniposide inhibited endothelial-mesenchymal transition via the mTOR signaling pathway in a bleomycin-induced scleroderma mouse model. Am J Transl Res 9:1025\u20131036","journal-title":"Am J Transl Res"},{"key":"4349_CR14","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1111\/bph.12355","volume":"170","author":"W Zhang","year":"2013","unstructured":"Zhang W, Chen G, Ren J, Zhao Y (2013) Bleomycin induces endothelial mesenchymal transition through activation of mTOR pathway: a possible mechanism contributing to the sclerotherapy of venous malformations. Br J Pharmacol 170:1210\u20131220","journal-title":"Br J Pharmacol"},{"key":"4349_CR15","doi-asserted-by":"publisher","first-page":"389582","DOI":"10.1155\/2014\/389582","volume":"2014","author":"B Grygiel-G\u00f3rniak","year":"2014","unstructured":"Grygiel-G\u00f3rniak B, Puszczewicz M (2014) Oxidative damage and antioxidative therapy in systemic sclerosis. Mediat Inflamm 2014:389582","journal-title":"Mediat Inflamm"},{"key":"4349_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tox.2011.03.001","volume":"283","author":"K Jomova","year":"2011","unstructured":"Jomova K, Valko M (2011) Advances in metal-induced oxidative stress and human disease. Toxicology 283:65\u201387","journal-title":"Toxicology"},{"key":"4349_CR17","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1096\/fj.201902063R","volume":"34","author":"H Tang","year":"2020","unstructured":"Tang H, Mao J, Ye X et al (2020) SHIP-1, a target of miR-155, regulates endothelial cell responses in lung fibrosis. FASEB J 34:2011\u20132023","journal-title":"FASEB J"},{"key":"4349_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1159\/000452547","volume":"40","author":"J Chao","year":"2016","unstructured":"Chao J, Wang X, Zhang Y et al (2016) Role of MCPIP1 in the endothelial-mesenchymal transition Induced by silica. Cell Physiol Biochem 40:309\u2013325","journal-title":"Cell Physiol Biochem"},{"key":"4349_CR19","doi-asserted-by":"publisher","first-page":"105968","DOI":"10.1016\/j.intimp.2019.105968","volume":"77","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Hu F, Li Q, Shen C, Yang J, Li M (2019) Tanshinone IIA ameliorates the bleomycin-induced endothelial-tomesenchymal transition via the Akt\/mTOR\/p70S6K pathway in a murine model of systemic sclerosis. Int Immunopharmacol 77:105968","journal-title":"Int Immunopharmacol"},{"key":"4349_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3109\/01902148.2014.979516","volume":"4","author":"JD Williamson","year":"2015","unstructured":"Williamson JD, Sadofsky LR, Hart SP (2015) The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis. Exp Lung Res 4:57\u201373","journal-title":"Exp Lung Res"},{"key":"4349_CR21","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.2353\/ajpath.2008.071049","volume":"172","author":"A Yoshizaki","year":"2008","unstructured":"Yoshizaki A, Iwata Y, Komura K et al (2008) CD19 regulates skin and lung fibrosis via toll-like receptor signaling in a model of bleomycin-induced scleroderma. Am J Pathol 172:1650\u20131663","journal-title":"Am J Pathol"},{"key":"4349_CR22","doi-asserted-by":"publisher","first-page":"11703","DOI":"10.1038\/ncomms11703","volume":"7","author":"S Bhattacharyya","year":"2016","unstructured":"Bhattacharyya S, Wang W, Morales-Nebreda L et al (2016) Tenascin-C drives persistence of organ fibrosis. Nat Commun 7:11703","journal-title":"Nat Commun"},{"key":"4349_CR23","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.3389\/fimmu.2018.02434","volume":"9","author":"S Bhattacharyya","year":"2018","unstructured":"Bhattacharyya S, Wang W, Tamaki Z et al (2018) Pharmacological inhibition of toll-like receptor-4 signaling by TAK242 prevents and induces regression of experimental organ fibrosis. Front Immunol 9:2434","journal-title":"Front Immunol"},{"key":"4349_CR24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.metabol.2017.07.007","volume":"76","author":"S Hong","year":"2017","unstructured":"Hong S, Choo E, Ihm S et al (2017) Dipeptidyl peptidase 4 inhibitor attenuates obesity-induced myocardial fibrosis by inhibiting transforming growth factor-\u03b2l and Smad2\/3 pathways in high-fat diet-induced obesity rat model. Metabolism 76:42\u201355","journal-title":"Metabolism"},{"key":"4349_CR25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4093\/dmj.2018.0271","volume":"44","author":"MJ Kim","year":"2019","unstructured":"Kim MJ, Kim NY, Jung YA et al (2019) Evogliptin, a dipeptidyl peptidase-4 inhibitor, attenuates renal fibrosis caused by unilateral ureteral obstruction in mice. Diabetes Metab J 44:186\u2013192","journal-title":"Diabetes Metab J"},{"key":"4349_CR26","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3389\/fphar.2017.00780","volume":"8","author":"Y Chang","year":"2017","unstructured":"Chang Y, Sun B, Han Z et al (2017) Saxagliptin attenuates albuminuria by inhibiting podocyte epithelialto-mesenchymal transition via SDF-1a in diabetic nephropathy. Front Pharmacol 8:780","journal-title":"Front Pharmacol"},{"key":"4349_CR27","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1139\/cjpp-2020-0049","volume":"99","author":"MA Elmaaboud","year":"2021","unstructured":"Elmaaboud MA, Khattab H, Shalaby S (2021) Hepatoprotective effect of linagliptin against liver fibrosis induced by carbon tetrachloride in mice. Can J Physiol Pharmacol 99:294\u2013302","journal-title":"Can J Physiol Pharmacol"},{"key":"4349_CR28","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.3389\/fimmu.2018.02452","volume":"9","author":"A Caam","year":"2018","unstructured":"Caam A, Vonk M, Hoogen F, Lent P, Kraan P (2018) Unraveling SSc pathophysiology: the myofibroblast. Front Immunol 9:2452","journal-title":"Front Immunol"},{"key":"4349_CR29","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/01.bor.0000139310.77347.9c","volume":"16","author":"AE Postlethwaite","year":"2004","unstructured":"Postlethwaite AE, Shigemitsu H, Kanangat S (2004) Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis. Curr Opin Rheumatol 16:733\u2013738","journal-title":"Curr Opin Rheumatol"},{"key":"4349_CR30","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.exphem.2010.03.004","volume":"38","author":"EL Herzog","year":"2010","unstructured":"Herzog EL, Bucala R (2010) Fibrocytes in health and disease. Exp Hematol 38:548\u2013556","journal-title":"Exp Hematol"},{"key":"4349_CR31","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15:178\u2013196","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4349_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12931-017-0660-4","volume":"18","author":"T Suzuki","year":"2017","unstructured":"Suzuki T, Tada Y, Gladson S et al (2017) Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition. Respir Res 18:177","journal-title":"Respir Res"},{"key":"4349_CR33","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.2337\/db13-1029","volume":"63","author":"K Kanasaki","year":"2014","unstructured":"Kanasaki K, Shi S, Kanasaki M et al (2014) Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen. Diabetes 63:2120\u20132131","journal-title":"Diabetes"},{"key":"4349_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1165\/rcmb.2009-0031OC","volume":"43","author":"N Hashimoto","year":"2010","unstructured":"Hashimoto N, Phan SH, Imaizumi K et al (2010) Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 43:161\u2013172","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4349_CR35","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1242\/jcs.028282","volume":"121","author":"T Kokudo","year":"2008","unstructured":"Kokudo T, Suzuki Y, Yoshimatsu Y, Yamazaki T, Watabe T, Miyazono K (2008) Snail is required for TGFbeta-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells. J Cell Sci 121:3317\u20133324","journal-title":"J Cell Sci"},{"key":"4349_CR36","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1165\/rcmb.2016-0323OC","volume":"58","author":"T Mammoto","year":"2018","unstructured":"Mammoto T, Muyleart M, Konduri GG, Mammoto A (2018) Twist1 in hypoxia-induced pulmonary hypertension through transforming growth factor-\u03b2-smad signaling. Am J Respir Cell Mol Biol 58:194\u2013207","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4349_CR37","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/ki.2015.103","volume":"88","author":"S Shi","year":"2015","unstructured":"Shi S, Srivastava SP, Kanasaki M et al (2015) Interactions of DPP-4 and integrin \u03b21 influences endothelial-to-mesenchymal transition. Kidney Int 88:479\u2013489","journal-title":"Kidney Int"},{"key":"4349_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/exd.13800","volume":"28","author":"Y Li","year":"2019","unstructured":"Li Y, Zhang L, Zhou Q et al (2019) Linagliptin inhibits high glucose-induced trans-differentiation of hypertrophic scar derived fibroblasts to myofibroblasts via IGF\/Akt\/mTOR signaling pathway. Exp Dermatol 28:19\u201327","journal-title":"Exp Dermatol"},{"key":"4349_CR39","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.3389\/fimmu.2018.01985","volume":"9","author":"DTB Thuan","year":"2018","unstructured":"Thuan DTB, Zayed H, Eid AH et al (2018) A potential link between oxidative stress and endothelial-to-mesenchymal transition in systemic sclerosis. Front Immunol 9:1985","journal-title":"Front Immunol"},{"key":"4349_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.freeradbiomed.2018.04.554","volume":"125","author":"S Svegliati","year":"2018","unstructured":"Svegliati S, Spadoni T, Moroncini G, Gabrielli A (2018) NADPH oxidase, oxidative stress and fibrosis in systemic sclerosis. Free Radic Biol Med 125:90\u201397","journal-title":"Free Radic Biol Med"},{"key":"4349_CR41","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1136\/annrheumdis-2011-200955","volume":"71","author":"K Khan","year":"2012","unstructured":"Khan K, Xu S, Nihtyanova S, Derrett-Smith E et al (2012) Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis. Ann Rheum Dis 71:1235\u20131242","journal-title":"Ann Rheum Dis"},{"key":"4349_CR42","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1756-185X.2012.01755.x","volume":"15","author":"Y Pehlivan","year":"2012","unstructured":"Pehlivan Y, Onat AM, Ceylan N et al (2012) Serum leptin, resistin and TNF-\u03b1 levels in patients with systemic sclerosis: the role of adipokines in scleroderma. Int J Rheum Dis 15:374\u2013379","journal-title":"Int J Rheum Dis"},{"key":"4349_CR43","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1165\/rcmb.2007-0299OC","volume":"38","author":"F Saito","year":"2008","unstructured":"Saito F, Tasaka S, Inoue K et al (2008) Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice. Am J Respir Cell Mol Biol 38:566\u2013571","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4349_CR44","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00395-019-0743-0","volume":"114","author":"Y Birnbaum","year":"2019","unstructured":"Birnbaum Y, Tran D, Bajaj M, Ye Y (2019) DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3\/ASC inflammasome. Basic Res Cardiol 114:35","journal-title":"Basic Res Cardiol"},{"key":"4349_CR45","doi-asserted-by":"publisher","first-page":"e0228750","DOI":"10.1371\/journal.pone.0228750","volume":"15","author":"MN Sonoda","year":"2020","unstructured":"Sonoda MN, Inoue T, Kimura S et al (2020) The dipeptidyl peptidase-4 inhibitor, linagliptin, improves cognitive impairment in streptozotocin-induced diabetic mice by inhibiting oxidative stress and microglial activation. PLoS One 15:e0228750","journal-title":"PLoS One"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04349-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-021-04349-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04349-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T22:08:46Z","timestamp":1666562926000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-021-04349-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,5]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["4349"],"URL":"https:\/\/doi.org\/10.1007\/s11010-021-04349-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-873241\/v1","asserted-by":"object"}]},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,5]]},"assertion":[{"value":"3 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm that they have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animals were treated with humane conditions and institutional guidelines for the care and use of animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}